483
MicroBiopharm Japan Co., Ltd.FDA 483 - MicroBiopharm Japan Co., Ltd. - February 09, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
MicroBioPharm Japan Co., Ltd. in Iwata, Japan, an API manufacturer, received three observations during an FDA inspection. The firm failed to establish adequate procedures for equipment cleaning and maintenance, and did not validate cleaning procedures. Additionally, the firm lacked appropriate written procedures for equipment qualification and performed inadequate process validations using unqualified equipment.
Open in Dashboard
ID · 4801bbc8-7f65-4bde-9a32-be6c47f8304d